A. Gilchrist

The Risk and Consequences of Clinical Miscoding Due to Inadequate Medical Documentation: A Case Study of the Impact on Health Services Funding

Kerin Robinson, Ping Cheng, A. Gilchrist, 2009, Health information management : journal of the Health Information Management Association of Australia.

Antibiotic resistant Gram-negative bacteria in long-term care facilities : an epidemiological and dynamic modelling study

A. Gilchrist, 2018 .

Pharmacogenomics spotlight commentary: From the United Kingdom to global populations

D. Hughes, E. Magavern, A. Daly, 2021, British journal of clinical pharmacology.

Urinary biomarker and histopathological evaluation of vancomycin and piperacillin-tazobactam nephrotoxicity in comparison with vancomycin in a rat model and a confirmatory cellular model

A. Zuppa, E. d’Aloja, A. Chalkias, 2019, bioRxiv.

Evaluation of Dose-Fractionated Polymyxin B on Acute Kidney Injury Using a Translational In Vivo Rat Model

A. Gilchrist, A. Hauser, Jiajun Liu, 2020, Antimicrobial Agents and Chemotherapy.

Evaluation of Dose Fractionated Polymyxin B on Acute Kidney Injury: A Translational In Vivo Model

A. Gilchrist, A. Hauser, Jiajun Liu, 2019, bioRxiv.

Prevalence of a Cefazolin Inoculum Effect Associated with blaZ Gene Types among Methicillin-Susceptible Staphylococcus aureus Isolates from Four Major Medical Centers in Chicago

C. Bethel, Kamaljit Singh, A. Charnot-Katsikas, 2018, Antimicrobial Agents and Chemotherapy.

Lack of synergistic nephrotoxicity between vancomycin and piperacillin/tazobactam in a rat model and a confirmatory cellular model.

A. Zuppa, E. d’Aloja, A. Chalkias, 2020, The Journal of antimicrobial chemotherapy.